If there's one thing blue-state liberals and Trump populists can agree on, it's that pharmaceutical firms charge too much for their drugs. That core belief has propelled Connecticut to the leading ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.